UCB Demonstrates Commitment to Science and Discovery Across Its Epilepsy Portfolio at the American Epilepsy Society’s Virtual Event AES2020

ATLANTA, Dec. 4, 2020 /PRNewswire/ — UCB today announced that 15 scientific posters will be presented at the upcoming American Epilepsy Society’s all new virtual event, AES2020, December 4-8, 2020. The scientific program features the latest research on VIMPAT in primary generalized tonic-clonic seizures (PGTCS). VIMPAT was just recently approved by the U.S. Food and Drug Administration (FDA) as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.1

Key poster presentations also include data on the long-term efficacy and tolerability of adjunctive BRIVIACT in adults with partial-onset seizures, the efficacy and patient satisfaction of NAYZILAM among people living with seizure clusters, and Phase 2 study results for Staccato® Alprazolam, an investigational drug-device combination designed to be used as a single-use epileptic seizure rescue therapy that combines the Staccato® delivery technology with alprazolam. Staccato® Alprazolam is not yet approved by the FDA.

Read More

StereoVision Imaging, Industry Leader in 4D FMCW LiDAR Technology, Adds Five New Continuation Patents to Extensive IP Portfolio

(MENAFN – GlobeNewsWire – Nasdaq) CALABASAS, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — [To enable links contact MENAFN] StereoVision[To enable links contact MENAFN] Imaging, Inc. (SVI) has been granted four new continuation patents by the United States Patent and Trademark Office (USPTO) and one new continuation patent issued by the European Patent Office. The patents build and expand upon the company’s extensive patent portfolio focused on biometric/object recognition and remote sensing technology.

The result of more than $100 million invested in R & D over the last 10 years, the new issuances bring SVI’s patent portfolio to 61 patents issued worldwide, with 46 patents pending across 24 patent families. They provide further protection for SVI’s Mil-Spec, field-proven and uniquely capable technology as it launches a new commercialization campaign.

‘These new patents both continue and broaden the protection of our technology portfolio focused on detecting and measuring moving objects in

Read More

NuVasive Unveils C360 Portfolio and Launches New Anterior Cervical Plate

“The unveiling of the C360 portfolio reflects NuVasive’s commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine,” said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. “As the leader in spine technology innovation, NuVasive saw an opportunity to procedurally integrate technology to support the cervical spine—as it did in the lateral market with X360®—to optimize the surgeon experience and advance care in the operating room. The launch of C360 is key to our long-term strategy and represents a significant opportunity for growth, as cervical spine procedures comprise an approximately $2.6 billion segment of the global spine market.”

The new ACP system challenges the status quo of cervical spine technology. It is designed to help reduce common postoperative complications, such as dysphagia, malalignment and adjacent level ossification, by enabling surgeons

Read More

Faraday Future Patent Portfolio Strength Validated by Randolph Square IP Study

  • The Patent Portfolio of Faraday Future Exceeds the Comparably Relevant Patents of Leading OEMs and Is on Par With Many EV Manufacturers Including Tesla

  • Faraday Future Has Nearly 880 Filed or Issued Patents Globally, With 530 Patents Granted Across Diversified Components, Technology and Processes

  • The Findings by Randolph Square IP Confirms Faraday Future’s Momentum in Automotive Innovation and Technology

Faraday Future (FF), a California-based global shared intelligent mobility ecosystem company, today announced that Randolph Square IP (RSIP), a patent data analytics firm, confirmed that FF’s diversified patent portfolio is more robust in comparable technologies than many leading OEMs including Toyota, Ford, and Honda. RSIP determined that FF’s expanding EV patent portfolio is on par with that of Tesla’s in key technologies.

RSIP’s findings state that the FF patent portfolio is comparatively young with an initial priority date of January 2015, noting that patents tend to strengthen as they age. The

Read More

H.I.G. Capital Portfolio Company Trace3 Continues Strategic Expansion with Groupware Technology Acquisition

H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $41 billion of equity capital under management, announced today that its portfolio company, Trace3 (“Company”), has acquired Groupware Technology (“Groupware”) to expand Trace3’s market position in Northern California and Arizona. Through elite-engineering and a continual focus on emerging technology, both companies are committed to assist their commercial and enterprise clients, including many of the Fortune 500, in realizing superior business outcomes through advanced technology solutions and services.

Headquartered in Campbell, CA., Groupware serves several Fortune 500 companies well-known for complex and challenging technology deployments. The newly combined company will serve as a leading technology solutions provider in Cloud, Data Intelligence, Security, and overall Enterprise IT.

The acquisition of Groupware by Trace3 continues a rich history of strategic and organic growth for the Company. With Trace3’s focus on innovation and emerging technology, expansion in Silicon Valley is a natural move

Read More

SANUWAVE Health Significantly Strengthens Intellectual Property Portfolio with Multiple Important Patent Grants for Its Shockwave Technology

US and International Patents Fortify dermaPACE Patent Position in Wound Care and Highlight its Innovation

Suwanee, GA – ( NewMediaWire ) – November 06, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has significantly strengthened its intellectual patent portfolio with the grants of a number of patents from the United States Patent and Trademark Office (USPTO) for the dermaPACE(R) System that further protect its unique and innovative shockwave technology in wound care.  In addition, the Company was also granted a patent related to the dermaPACE(R) System from IP Australia. 

“At SANUWAVE, we have long recognized the unique value that our non-invasive, shockwave technology provides in healing chronic wounds and these patents reinforce this belief, further demonstrating the proprietary nature of

Read More

Siemens Expands Xcelerator Portfolio with Enhanced Model Based Definition in Latest Version of NX Software

  • November 06, 2020
  • Siemens

Siemens Expands Xcelerator Portfolio with Enhanced Model Based Definition in Latest Version of NX Software

Siemens Digital Industries Software announces the availability of the latest version of NX™ software, including capabilities that allow companies to use a rules and knowledge-based approach to Model Based Definition, which builds in best practices and leverages artificial intelligence to dramatically improve productivity.

NX Model Based Definition provides a rich set of data that defines a variety of characteristics beyond size and shape to enable a truly comprehensive digital twin. By including non-geometric data within the CAD model, engineers can now produce a complete digital definition of a product in an annotated and organized manner, creating alignment throughout the production process, from design to production through validation.

 



NX PMI Advisor for validation and guidance


 

“I’ve been in the CAD/PLM game my entire

Read More

Airocide Acquisition to Widen the Disinfection Technology Portfolio

– By Ishan Majumdar

The acquisition of new technologies is important for the growth of a company in virtually any sector, but has become particularly relevant within the disinfection technologies space given the ongoing Covid-19 pandemic. Hence, the recent acquisition announcement by the management of disinfection technology player Applied UV Inc. (NASDAQ:AUVI) does not come as a big surprise. The New York-based company announced the signing of a non-binding letter of intent with its distribution partner, Akida Holdings, to acquire certain assets, including its rights to manufacture and sell the Airocide disinfection technology.

Background of the transaction

Applied UV has been on my watch list ever since it went public. The company was in the news for its exclusive joint distribution and licensing agreement with Akida Holdings in September. Following it public offering, a large amount of the funds raised were earmarked specifically for the acquisition of new technologies. The

Read More

Coretelligent, LLC. and VSS Announce Acquisition of Soundshore Technology Group, Further Expanding Upon Robust Financial Services Portfolio

Coretelligent, a leading provider of comprehensive managed IT, security and unified cloud management services, and a portfolio company of VSS Capital Partners (“VSS”), a private investment firm, today jointly announced the acquisition of managed services IT firm Soundshore Technology Group. Financial terms of the private transaction were not disclosed.

Soundshore Technology Group (STG) brings over 22 years of experience supporting alternative investment firms in Connecticut, New York City and Los Angeles. STG acts as the managed service provider for over 70 hedge funds, private equity/VCs, RIA firms and Family Offices nationwide.

“We’re delighted to welcome the Soundshore team and their world-class clientele to the Coretelligent family. The shared commitment to delivering a superlative IT experience to our collective clients made bringing the two firms together a natural decision,” said Coretelligent Founder, President, and CEO, Kevin J. Routhier. “The acquisition of STG greatly compliments and further strengthens Coretelligent’s iron-clad platform

Read More

Why one portfolio manager has gone all-in on emerging markets ahead of the U.S. election

Emerging markets turned positive for the year this week, and Washington Crossing Advisors’ Chad Morganlander said their performance could get even better.

Trading Nation: Why emerging markets could benefit from the election outcome

UP NEXT

UP NEXT

“We are overweight this sector for the first time in three years,” Morganlander, a portfolio manager at his firm, told CNBC’s “Trading Nation” on Monday. “The big picture is that 85% of the global population is domiciled in emerging markets with less than 50% of global GDP. We see the emerging markets as better relative value as well as growth.”

Loading...

Load Error

While emerging markets could be impacted by the results of the U.S. election, Morganlander said his call is not tied to the outcome. Instead, he sees opportunity in the global economic recovery from the coronavirus crisis.

“As we go into 2021 in the later half, we think that as Covid

Read More